• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    EDAP Appoints Medical Capital Equipment Finance Veteran Ken Mobeck as Chief Financial Officer of Company's U.S. Subsidiary

    12/6/22 8:00:00 AM ET
    $ARAY
    $EDAP
    $HPQ
    $INTC
    Medical/Dental Instruments
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $ARAY alert in real time by email

    LYON, France, December 6, 2022 -- EDAP TMS SA (NASDAQ:EDAP) (the "Company"), the global leader in robotic energy-based therapies, announced today that the Company has hired medical capital equipment finance industry veteran Ken Mobeck as Chief Financial Officer of EDAP Technomed Inc., the Company's U.S. subsidiary. During his extensive career, Mr. Mobeck has demonstrated significant leadership expertise in driving transformational business growth while establishing a track record of creating lasting shareholder value.

    Marc Oczachowski, Chairman and Chief Executive Officer of EDAP TMS, stated, "I am very pleased to welcome Ken onboard our U.S. subsidiary. Ken is a great addition to Ryan Rhodes's leadership team and will be key to supporting the ongoing expansion of our U.S. organization and driving the continued strong growth of our business in the U.S."

    Ryan Rhodes, Chief Executive Officer of EDAP Technomed Inc., stated, "Ken is the ideal candidate to be our subsidiary's first CFO as we begin to significantly ramp up the business with the growth of our flagship Focal One® Robotic HIFU platform. He brings over 25 years of financial leadership across all finance disciplines with extensive experience building strong relationships to drive operating results. His knowledge of capital equipment along with his medical device and investor relations experience at leading organizations, including Accuray, will be invaluable as we move forward."

    "EDAP Technomed Inc. is at a critical juncture in the organization's growth. I'm looking forward to working with Ryan and the extended team to accelerate growth in our U.S. business and provide more patients with access to our precise, innovative Focal One robotic technology," said Mr. Mobeck.

    Prior to joining EDAP Technomed, Ken served as Vice President of Finance and Investor Relations at medical device manufacturer Accuray Incorporated (NASDAQ:ARAY), one of the leading radiation therapy companies in the industry. During his tenure with the organization, he was responsible for driving key initiatives to improve the company's operating performance. Prior to joining Accuray, Ken served as Vice President of Finance at optical networking leader Lumentum (NASDAQ:LITE) where he helped raise $900 million in debt financing to grow the business from $900 million to more than $1.6 billion in only three years. Before Lumentum, he spent over two decades in positions with increasing levels of responsibility at some of Silicon Valley's most innovative companies including Silicon Graphics, Hewlett Packard (NYSE:HPQ), KLA (NASDAQ:KLAC) and Intel Corporation (NASDAQ:INTC), where he was involved in high scale growth, business transformation and mergers and acquisitions. Notably, while employed at KLA, he helped grow revenue from $1.3 billion to $2.7 billion over seven years.

    About EDAP TMS SA

    A recognized leader in the global therapeutic ultrasound market. EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in Europe and in the U.S. as an answer to all requirements for ideal prostate tissue ablation. With the addition of the ExactVu™ Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer. EDAP TMS also produces and distributes other medical equipment including the Sonolith® i-move lithotripter and lasers for the treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL). For more information on the Company, please visit http://www.edap-tms.com, us.hifu-prostate.com and www.focalone.com.

    Forward-Looking Statements

    In addition to historical information, this press release contains forward-looking statements. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties, including matters not yet known to us or not currently considered material by us, and there can be no assurance that anticipated events will occur or that the objectives set out will actually be achieved. Important factors that could cause actual results to differ materially from the results anticipated in the forward-looking statements include, among others, the clinical status and market acceptance of our HIFU devices and the continued market potential for our lithotripsy device, as well as the length and severity of the recent COVID-19 outbreak, including its impacts across our businesses on demand for our devices and services. Factors that may cause such a difference also may include, but are not limited to, those described in the Company's filings with the Securities and Exchange Commission and in particular, in the sections "Cautionary Statement on Forward-Looking Information" and "Risk Factors" in the Company's Annual Report on Form 20-F.

    Company Contact

    Blandine Confort

    Investor Relations / Legal Affairs

    EDAP TMS SA

    +33 4 72 15 31 50

    [email protected]

    Investor Contact

    John Fraunces

    LifeSci Advisors, LLC

    212-915-2568

    [email protected]

     



    Primary Logo

    Get the next $ARAY alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARAY
    $EDAP
    $HPQ
    $INTC

    CompanyDatePrice TargetRatingAnalyst
    Intel Corporation
    $INTC
    9/25/2025Sell → Neutral
    Seaport Research Partners
    Intel Corporation
    $INTC
    9/22/2025Sell → Hold
    Erste Group
    KLA Corporation
    $KLAC
    9/22/2025$1093.00Overweight → Equal-Weight
    Morgan Stanley
    Intel Corporation
    $INTC
    9/19/2025$29.00Neutral → Sell
    Citigroup
    Intel Corporation
    $INTC
    9/19/2025$43.00Hold → Buy
    The Benchmark Company
    HP Inc.
    $HPQ
    9/16/2025$30.00Mkt Perform
    Bernstein
    HP Inc.
    $HPQ
    9/10/2025$29.00Outperform → In-line
    Evercore ISI
    Lumentum Holdings Inc.
    $LITE
    8/29/2025$165.00Buy
    Citigroup
    More analyst ratings

    $ARAY
    $EDAP
    $HPQ
    $INTC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Whitters Joseph E bought $62,335 worth of shares (50,000 units at $1.25), increasing direct ownership by 9% to 611,053 units (SEC Form 4)

    4 - ACCURAY INC (0001138723) (Issuer)

    6/16/25 4:10:10 PM ET
    $ARAY
    Medical/Dental Instruments
    Health Care

    CEO Gelsinger Patrick P bought $251,198 worth of shares (11,150 units at $22.53), increasing direct ownership by 12% to 105,033 units (SEC Form 4)

    4 - INTEL CORP (0000050863) (Issuer)

    11/6/24 4:06:28 PM ET
    $INTC
    Semiconductors
    Technology

    CEO Gelsinger Patrick P bought $251,946 worth of shares (12,500 units at $20.16) (SEC Form 4)

    4 - INTEL CORP (0000050863) (Issuer)

    8/7/24 4:23:22 PM ET
    $INTC
    Semiconductors
    Technology

    $ARAY
    $EDAP
    $HPQ
    $INTC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, Semi. Prod. & Cust. Khan Ahmad A. sold $4,107,600 worth of shares (4,564 units at $900.00), decreasing direct ownership by 17% to 22,808 units (SEC Form 4)

    4 - KLA CORP (0000319201) (Issuer)

    9/9/25 4:05:05 PM ET
    $KLAC
    Electronic Components
    Technology

    Director Francisco Ma. Fatima gifted 19,136 shares and received a gift of 19,136 shares, closing all direct ownership in the company (SEC Form 4)

    4 - HP INC (0000047217) (Issuer)

    9/5/25 6:07:36 PM ET
    $HPQ
    Computer Manufacturing
    Technology

    CVP, Chief Accounting Officer Gawel Scott covered exercise/tax liability with 6,100 shares and converted options into 12,303 shares, increasing direct ownership by 27% to 29,138 units (SEC Form 4)

    4 - INTEL CORP (0000050863) (Issuer)

    9/4/25 4:26:27 PM ET
    $INTC
    Semiconductors
    Technology

    $ARAY
    $EDAP
    $HPQ
    $INTC
    SEC Filings

    View All

    SEC Form S-8 filed by EDAP TMS S.A.

    S-8 - EDAP TMS SA (0001041934) (Filer)

    9/30/25 5:04:15 PM ET
    $EDAP
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 144 filed by HP Inc.

    144 - HP INC (0000047217) (Subject)

    9/29/25 4:28:31 PM ET
    $HPQ
    Computer Manufacturing
    Technology

    Intel Corporation filed SEC Form 8-K: Unregistered Sales of Equity Securities

    8-K - INTEL CORP (0000050863) (Filer)

    9/29/25 4:09:16 PM ET
    $INTC
    Semiconductors
    Technology

    $ARAY
    $EDAP
    $HPQ
    $INTC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Intel upgraded by Seaport Research Partners

    Seaport Research Partners upgraded Intel from Sell to Neutral

    9/25/25 8:22:52 AM ET
    $INTC
    Semiconductors
    Technology

    Intel upgraded by Erste Group

    Erste Group upgraded Intel from Sell to Hold

    9/22/25 8:38:35 AM ET
    $INTC
    Semiconductors
    Technology

    KLA Corporation downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded KLA Corporation from Overweight to Equal-Weight and set a new price target of $1,093.00

    9/22/25 8:28:31 AM ET
    $KLAC
    Electronic Components
    Technology

    $ARAY
    $EDAP
    $HPQ
    $INTC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Accuray and the University of Wisconsin-Madison Announce Memorandum of Understanding to Advance Online Adaptive Radiotherapy in Support of Improving Cancer Patient Care

    MADISON, Wis., Sept. 30, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced today the signing of a memorandum of understanding (MOU) to advance online adaptive radiotherapy (OART) on the Accuray helical radiation treatment delivery platform. As part of the MOU, the two parties outlined their intent to collaborate on clinical research, education and training, and adaptive technology development, to help empower medical care teams to raise the bar in the personalization and precision of cancer care.

    9/30/25 7:35:00 AM ET
    $ARAY
    Medical/Dental Instruments
    Health Care

    Focal One® Prostate Cancer Awareness Month Campaign Shines Spotlight on Robotic HIFU Treatment Option

    Focal One® Prostate Cancer Awareness Month Campaign Shines Spotlight on Robotic HIFU Treatment Option Focal One Robotic HIFU Patient Story Featured on Health Uncensored with Dr. Drew on Lifetime Network  AUSTIN, Texas – September 30, 2025 – EDAP TMS SA (NASDAQ:EDAP), a global leader in robotic energy-based therapies, announced that its non-invasive, nonsurgical treatment option, Focal One Robotic HIFU, was featured on national television on Friday, September 26, reaching millions of viewers nationwide. The segment, which included an interview with a patient treated with Focal One, aired during an episode of Health Uncensored with Dr. Drew on the Lifetime Network, as part of the company's P

    9/30/25 7:00:00 AM ET
    $EDAP
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Lumentum Showcases New Products and Technologies at ECOC 2025 for AI and Data Center Networks

    Lumentum Holdings Inc. ("Lumentum"), a global leader in optical and photonic technology, today announced several live technology and product demonstrations at ECOC, the European Conference on Optical Communications, reinforcing the company's focus on enabling AI-driven data centers and the world's largest communications networks. Visit Lumentum's stand #C2421 at the Bella Center in Copenhagen, Denmark from September 29 - October 1. Lumentum's cutting-edge photonics and laser chip technologies drive the backbone of global network infrastructure. From optical transceivers within data centers to DCI links, long-haul transmission systems, subsea cables, and edge networks, our solutions delive

    9/29/25 4:18:00 AM ET
    $LITE
    Telecommunications Equipment
    Telecommunications

    $ARAY
    $EDAP
    $HPQ
    $INTC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Lumentum Holdings Inc.

    SC 13G/A - Lumentum Holdings Inc. (0001633978) (Subject)

    11/14/24 7:53:37 PM ET
    $LITE
    Telecommunications Equipment
    Telecommunications

    Amendment: SEC Form SC 13G/A filed by EDAP TMS S.A.

    SC 13G/A - EDAP TMS SA (0001041934) (Subject)

    11/14/24 3:36:33 PM ET
    $EDAP
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13G/A filed by HP Inc.

    SC 13G/A - HP INC (0000047217) (Subject)

    11/12/24 3:53:24 PM ET
    $HPQ
    Computer Manufacturing
    Technology

    $ARAY
    $EDAP
    $HPQ
    $INTC
    Financials

    Live finance-specific insights

    View All

    EDAP Reports Strong Second Quarter 2025 HIFU Results

    +140% Focal One® Net Placement Growth Year over Year+76.8% HIFU Revenue Growth Year over Year 36 million Euro Credit Facility Letter of Intent Executed with European Investment Bank (EIB) to further accelerate HIFU Growth and Strategic Expansion Company raises 2025 HIFU Year over Year Revenue Growth Guidance range to 26% to 34%, up from the prior range of 16% to 25%  Company to Host Conference Call and Webcast Today, August 28th, at 8:30 a.m. EDT  AUSTIN, Texas, August 28, 2025 - EDAP TMS SA (NASDAQ:EDAP), the global leader in robotic energy-based therapies, reported today unaudited consolidated financial results for the second quarter of 2025. "We experienced our strongest second quarter

    8/28/25 7:00:00 AM ET
    $EDAP
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    HP Inc. Reports Fiscal 2025 Third Quarter Results

    PALO ALTO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- HP (NYSE:HPQ) Third quarter GAAP diluted net earnings per share ("EPS") of $0.80, up 23.1% from the prior year period Third quarter non-GAAP diluted net EPS of $0.75, down 10.7% from the prior year period Third quarter net revenue of $13.9 billion, up 3.1% from the prior-year period Third quarter net cash provided by operating activities of $1.7 billion, free cash flow of $1.5 billion Third quarter returned $0.4 billion to shareholders in the form of dividend and share repurchases HP Inc.'s fiscal 2025 third quarter financial performance Q3 FY25 Q3 FY24 Y/YGAAP net revenue ($B)$13.9  $13.5  3.1 %GAAP

    8/27/25 4:05:00 PM ET
    $HPQ
    Computer Manufacturing
    Technology

    Updated time: HP Inc. to Announce Third Quarter Fiscal 2025 Earnings on Aug 27, 2025

    PALO ALTO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- HP Inc. (NYSE:HPQ) will present a live audio webcast of a conference call to review financial results for the third fiscal quarter ended July 31, 2025 on Wednesday, Aug 27, 2025 at 4:30 p.m. ET / 1:30 p.m. PT. The webcast will be available at www.hp.com/investor/2025Q3Webcast. A replay of the audio webcast will be available at the same website shortly after the call and will remain available for approximately one year. About HP Inc. HP Inc. (NYSE:HPQ) is a global technology leader and creator of solutions that enable people to bring their ideas to life and connect to the things that matter most. Operating in more than

    8/14/25 4:15:00 PM ET
    $HPQ
    Computer Manufacturing
    Technology

    $ARAY
    $EDAP
    $HPQ
    $INTC
    Leadership Updates

    Live Leadership Updates

    View All

    Pitney Bowes Appoints Accomplished Shipping and Technology Leader Todd Everett as President of Sending Technology Solutions

    Also Appoints Experienced Public Company Director Wayne Walker as Independent Member of the Board Announces Actions to Help Realize the Full Value of The Pitney Bowes Bank and the Company's Global Financial Services Business Pitney Bowes Inc. (NYSE:PBI) ("Pitney Bowes" or, the "Company"), a technology-driven products and services company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the world, today announced the following actions associated with the initial phase of its strategic review announced in May 2025: The Appointment of Todd Everett as EVP and President of Sending Technology Solutions ("SendTech"): Mr. Everett has approxi

    9/12/25 8:10:00 AM ET
    $INTC
    $PBI
    $POWW
    Semiconductors
    Technology
    Office Equipment/Supplies/Services
    Miscellaneous

    Oncology Innovation Just Hit a Turning Point -- Here's What to Watch

    USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 30, 2025 /PRNewswire/ -- USA News Group News Commentary – The oncology landscape is being pulled in two directions. On one hand, U.S. cancer death rates continue to decline. On the other, global cases are expected to rise sharply—while early-onset diagnoses in younger patients are climbing at a troubling pace. At the same time, proposed federal budget cuts threaten to slash funding for the National Cancer Institute by up to 40%, raising concerns about the future of publicly funded research. With public resources under pressure, much of the innovation burden is shifting to the private sector, where a

    6/30/25 11:02:00 AM ET
    $ARAY
    $CLRB
    $ERAS
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Biotechnology: Biological Products (No Diagnostic Substances)

    Blues Welcomes Silicon Valley Veteran Ian Small as CEO to Deepen Customer Focus and Drive Expansion

    BOSTON, June 24, 2025 /PRNewswire/ -- Blues, a leader in IoT connectivity solutions, today announced that former Evernote Chief Executive Officer (CEO) Ian Small has joined the company as CEO. Small, who has more than 30 years of technology-industry experience, brings deep operational expertise and a track record of scaling companies from early-stage through public-market maturity. Small is widely recognized as an end-to-end operator with the ability to drive growth across every stage of the business lifecycle. He brings a standout reputation for listening to customers and tur

    6/24/25 6:00:00 AM ET
    $LITE
    Telecommunications Equipment
    Telecommunications